Literature DB >> 3258945

Late results of ascending aorta-descending aorta bypass grafts for recurrent coarctation of aorta.

T Jacob1, A Cobanoglu, A Starr.   

Abstract

Ten patients between the ages of 10 and 17 years underwent ascending aorta-descending aorta bypass grafts for recurrent coarctation at the Oregon Health Sciences University from 1975 to 1984. The combined approach through a left thoracotomy and median sternotomy was used in all the patients. This operation was used when the segment of recoarctation was long, dense adhesions were present, collaterals were inadequate, or when a cardiac operation was necessary for an associated lesion. All the patients survived the operation, and the long-term results to date have been satisfactory.

Entities:  

Mesh:

Year:  1988        PMID: 3258945

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Surgical treatment for graft stenosis after repair of an interrupted aortic arch: report of two cases.

Authors:  T Kosuga; S Fukunaga; K Akasu; S Chihara; S Yokose; H Akashi; T Kawara; K I Kosuga; S Aoyagi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  New technique for single-staged repair of aortic coarctation and coexisting cardiac disorder.

Authors:  Askin Ali Korkmaz; Mustafa Guden; Burak Onan; Sevim Indelen Tarakci; Ali Soner Demir; Ertan Sagbas; Tugay Sarikaya
Journal:  Tex Heart Inst J       Date:  2011

3.  Axillofemoral bypass for recurrent atypical coarctation of the thoracic aorta. Woman in childbearing age.

Authors:  T Harada; K Nakayama; T Kitano; H Sakaguchi; K Minami
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-09

4.  Two stage hybrid approach for complex aortic coarctation repair.

Authors:  Efstratios Koletsis; Stella Ekonomidis; Nikolaos Panagopoulos; George Tsaousis; James Crockett; Matthew Panagiotou
Journal:  J Cardiothorac Surg       Date:  2009-02-24       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.